Morgan Stanley
MS
$214.98
+1.88%
Morgan Stanley is a global financial services firm operating primarily in the Capital Markets industry, with core businesses spanning investment banking, institutional securities trading, wealth management, and investment management. The company is a market leader and a premier global investment bank, distinguished by its massive wealth and asset management franchises, which now generate the lion's share of its income and hold over $9.3 trillion in client assets. The current investor narrative is focused on the firm's ability to capitalize on market volatility and a resurgent M&A cycle, as evidenced by recent record trading quarters driven by geopolitical events, while debates center on the sustainability of its growth across both its institutional and stable wealth management segments.…
MS
Morgan Stanley
$214.98
Related headlines
Investment Opinion: Should I buy MS Today?
Rating & Thesis: Hold. Morgan Stanley is a high-quality franchise with a transformed, more stable business model, but its current price near all-time highs and premium valuation limits near-term upside, making it prudent to await a better entry point. This aligns with the analyst consensus which, while bullish, shows a period of steady ratings without major new upgrades.
Supporting Evidence: The stock trades at a forward PE of 16.38x, a premium to the financial sector, justified by its superior 15.1% ROE and 11.1% YoY revenue growth. However, the implied upside to the average analyst EPS target of $15.38 is muted at the current valuation. Profitability is strong with a 14.66% net margin, but the negative TTM FCF of -$17.89B and high D/E ratio of 4.26 temper the bullish case. The PEG ratio of 0.58 is attractive but may not be a primary driver for financial stock investors.
Risks & Conditions: The two biggest risks are a market correction exposing the stock's high beta (1.21) and a slowdown in capital markets activity pressuring cyclical revenue segments. This Hold would upgrade to a Buy if the PE multiple compresses to near 14x (implying a price near $180) or if quarterly revenue growth accelerates sustainably above 15%. It would downgrade to a Sell if revenue growth turns negative or the debt-to-equity ratio escalates above 5.0. Relative to its history and peers, the stock is fairly valued to slightly overvalued, pricing in near-perfect execution of its growth narrative.
Sign up to view all
MS 12-Month Price Forecast
Morgan Stanley is a fundamentally strong company caught in a tactically challenging position. Its transformed business model deserves a premium, but the stock's 62% one-year rally and proximity to all-time highs suggest much of the positive narrative is priced in. The base case of moderate growth and range-bound trading is most probable. The stance would upgrade to Bullish on a meaningful pullback (10-15%) that improves the risk/reward profile, or if quarterly earnings demonstrate accelerating growth in the wealth segment alongside a rebounding investment banking pipeline. It would turn Bearish if technical support at $180 breaks decisively on high volume, signaling a failure of the uptrend.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Morgan Stanley's 12-month outlook, with a consensus price target around $279.47 and implied upside of +30.0% versus the current price.
Average Target
$279.47
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$172 - $279
Analyst target range
Analyst coverage for Morgan Stanley is robust, with 7 analysts providing estimates. The consensus sentiment leans bullish, as reflected in recent institutional ratings where firms like Barclays and Keefe, Bruyette & Woods maintain 'Overweight' or 'Outperform' ratings, while JP Morgan holds a 'Neutral' stance. The average revenue estimate for the coming period is $93.90 billion, with a range from $90.46 billion to $96.38 billion, and the average EPS estimate is $15.38. The wide target range for revenue, spanning nearly $6 billion, signals a degree of uncertainty regarding the precise growth trajectory, influenced by volatile capital markets and interest rate environments. The tight clustering of recent analyst actions around maintaining existing ratings, rather than major upgrades or downgrades, suggests a period of steady, consensus bullishness without new, overwhelming catalysts.
Bulls vs Bears: MS Investment Factors
The evidence currently favors the bull case, driven by powerful technical momentum, robust profitability metrics, and a consensus bullish analyst view anchored in the firm's successful business model shift. However, the bear case presents credible risks centered on valuation extension, high leverage, and cyclical dependence. The single most important tension in the investment debate is whether the market is justified in applying a premium valuation (16.54x PE) for Morgan Stanley's stable wealth management earnings stream, or if this premium will compress during the next market downturn, exposing the stock's cyclical vulnerabilities and high beta.
Bullish
- Powerful Technical Momentum: The stock is up 62.3% over the past year and 24.9% over the past three months, significantly outperforming the SPY. It is trading just $0.06 below its 52-week high of $208.06, indicating strong institutional buying pressure and a sustained uptrend.
- Strong Profitability & ROE: Morgan Stanley reported a Q4 2025 net margin of 14.66% and an operating margin of 19.1%. Its return on equity of 15.1% demonstrates highly efficient use of shareholder capital, justifying a valuation premium over less profitable peers.
- Resilient Revenue Growth: Q4 2025 revenue grew 11.1% year-over-year to $28.86 billion, continuing a multi-quarter positive trajectory. The Wealth Management segment ($8.43B) is now a stable, high-margin growth driver alongside the volatile Institutional Securities business.
- Analyst Consensus Bullishness: Analyst sentiment leans bullish, with firms like Barclays and Keefe, Bruyette & Woods maintaining 'Overweight' ratings. The average EPS estimate of $15.38 implies confidence in continued earnings power, supported by a favorable M&A and trading cycle.
Bearish
- Extended Valuation & Technical Resistance: The stock trades at a trailing PE of 16.54x, above its recent historical range and at a premium to the broader Financial Services sector. With the price at the 52-week high, it faces immediate technical resistance and is vulnerable to a sharp pullback.
- High Financial Leverage: The company's debt-to-equity ratio of 4.26 is significant, typical for a global bank but a source of risk in a rising rate or credit-tightening environment. This leverage amplifies both gains and potential losses.
- Negative Free Cash Flow: Trailing twelve-month free cash flow is negative $17.89 billion, which, while common for financial institutions due to accounting treatment, limits financial flexibility and complicates valuation based on cash generation.
- Market Volatility & High Beta: A beta of 1.21 indicates the stock is 21% more volatile than the broader market. This makes it susceptible to sharp downdrafts during market corrections, as evidenced by its 19.28% maximum drawdown in the provided period.
MS Technical Analysis
The stock is in a powerful, sustained uptrend, evidenced by a 62.3% gain over the past year. As of the latest close at $208, the price is trading at the very top of its 52-week range, just $0.06 below its 52-week high of $208.06, indicating strong momentum but also potential overextension and vulnerability to a pullback from resistance. Recent momentum is exceptionally strong and accelerating, with the stock up 11.2% over the past month and 24.9% over the past three months, significantly outpacing the SPY's gains of 6.3% and 10.3% over the same periods, respectively. This short-term surge aligns with and reinforces the longer-term bullish trend, suggesting continued institutional buying pressure. Key technical support is anchored at the 52-week low of $126.35, while immediate resistance is the 52-week high at $208.06. A decisive breakout above this level could signal a continuation of the rally, while a failure and reversal would suggest a near-term top. The stock's beta of 1.21 indicates it is approximately 21% more volatile than the broader market, which investors must factor into risk management and position sizing decisions.
Beta
1.21
1.21x market volatility
Max Drawdown
-19.3%
Largest decline past year
52-Week Range
$127-$217
Price range past year
Annual Return
+67.4%
Cumulative gain past year
| Period | MS Return | S&P 500 |
|---|---|---|
| 1m | +13.0% | +5.4% |
| 3m | +28.3% | +10.9% |
| 6m | +22.9% | +11.0% |
| 1y | +67.4% | +28.1% |
| ytd | +18.2% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MS Fundamental Analysis
Revenue growth has been solid, with the most recent Q4 2025 revenue of $28.86 billion representing an 11.1% year-over-year increase. The multi-quarter trend shows revenue has grown from $25.35 billion in Q1 2024 to the current level, indicating a generally positive trajectory, though quarterly results can be volatile; segment data from a recent quarter shows the Wealth Management segment ($8.43B) slightly outpacing Institutional Securities ($7.93B) as key growth drivers. The company is highly profitable, reporting Q4 2025 net income of $4.40 billion and a net margin of 14.66%. Gross margin for the quarter was a healthy 58.0%, and the operating margin was 19.1%, demonstrating strong core profitability, though margins can fluctuate quarter-to-quarter based on trading and investment banking performance. The balance sheet carries significant leverage typical for a global bank, with a debt-to-equity ratio of 4.26, but this is managed alongside substantial liquidity, evidenced by a current ratio of 1.17. Trailing twelve-month free cash flow is negative at -$17.89 billion, which is not uncommon for financial institutions due to the treatment of trading and lending activities, but the firm's return on equity of 15.1% indicates efficient use of shareholder capital.
Quarterly Revenue
$28.9B
2025-12
Revenue YoY Growth
+0.11%
YoY Comparison
Gross Margin
+0.58%
Latest Quarter
Free Cash Flow
$-17.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MS Overvalued?
Given a positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 16.54x, while the forward PE is slightly lower at 16.38x, indicating the market expects roughly stable earnings growth in the near term. Compared to sector averages, Morgan Stanley's trailing PE of 16.54x trades at a premium to the broader Financial Services sector average (typically in the low teens), but this premium is justified by its superior mix of high-margin, stable wealth management revenue and strong ROE of 15.1%. Historically, the stock's own PE ratio has ranged significantly; the current trailing PE of 16.54x is above its recent quarterly average from the provided historical data (which often showed PEs between 10x and 16x), suggesting the market is pricing in optimistic expectations near the higher end of its recent valuation band, supported by the strong price performance and earnings growth.
PE
16.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 8x~25x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
24.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Morgan Stanley carries substantial financial leverage with a debt-to-equity ratio of 4.26, which, while managed, increases interest rate sensitivity and risk during credit contractions. Earnings exhibit quarterly volatility, with revenue ranging from $25.35 billion to $30.05 billion over the last eight quarters, reflecting dependence on unpredictable trading and investment banking fees. The negative TTM free cash flow of -$17.89 billion, though standard for the industry, indicates that traditional cash flow-based valuation metrics are less reliable, and capital allocation is heavily influenced by balance sheet management rather than organic cash generation.
Market & Competitive Risks: The stock trades at a premium valuation with a trailing PE of 16.54x, above both its own historical range and the typical low-teens multiple for the Financial Services sector, creating valuation compression risk if growth expectations are not met. Its high beta of 1.21 makes it highly sensitive to broader market downturns and sector rotations away from financials. Competitive pressure is intense from both bulge-bracket peers (like Goldman Sachs, which recently reported a 48% surge in investment banking fees) and fintech disruptors in wealth management, threatening margins and market share.
Worst-Case Scenario: A severe recession coupled with a sustained bear market would trigger a chain of events: capital markets activity dries up, crushing investment banking and trading revenue; wealth management assets under management shrink, pressuring fees; credit losses rise; and the high financial leverage magnifies the earnings decline. This could lead to multiple compression towards the sector's lower valuation range. The realistic downside from the current price of $208 is approximately -39% to the 52-week low of $126.35, though a more probable adverse scenario might see a drawdown of 20-25% to the $155-$165 range, aligning with recent support levels and a de-rating to a ~13x PE multiple.
FAQ
The key risks are, in order of severity: 1) Market & Cyclical Risk: High beta (1.21) and dependence on capital markets activity make earnings volatile; a market downturn could trigger a ~20%+ drawdown. 2) Financial Risk: Significant leverage with a debt-to-equity ratio of 4.26 increases vulnerability to rising rates and credit stress. 3) Valuation Risk: Trading at a premium PE (16.54x) creates compression risk if growth disappoints. 4) Operational Risk: Negative TTM free cash flow of -$17.89B, while standard, limits financial flexibility and complicates analysis.
The 12-month forecast presents three scenarios. The Base Case (55% probability) sees the stock trading between $200 and $220, as it executes on moderate growth in line with analyst estimates for $93.9B in revenue. The Bull Case (30% probability) targets $225-$240, driven by a stronger-than-expected capital markets cycle and multiple expansion. The Bear Case (15% probability) warns of a drop to $155-$175 in a market downturn that compresses its premium valuation. The base case is most likely, assuming no major economic shocks.
MS is fairly valued to slightly overvalued relative to its immediate history and the financial sector, but the premium is justified by its business mix. Its trailing PE of 16.54x is above the typical low-teens multiple for financials, reflecting the market's willingness to pay for its high-margin, stable wealth management earnings and superior 15.1% ROE. The PEG ratio of 0.58 suggests undervaluation on a growth-adjusted basis, but this metric is less emphasized for banks. The valuation implies the market expects continued execution on both stable fee growth and cyclical revenue recovery.
MS is a high-quality stock, but its attractiveness as a 'buy' is highly time-sensitive. At the current price of $208, just below its 52-week high and trading at a premium PE of 16.54x, the near-term risk/reward is balanced to slightly unfavorable. It would be a good buy for long-term investors on a pullback to the $180-$190 range, which would offer a better entry point into its strong franchise. The stock is a good buy for those who believe the M&A and trading cycle has further room to run and are willing to accept above-market volatility (beta 1.21).
MS is best suited for a long-term investment horizon of 3-5 years. Its high beta (1.21) and cyclical exposure make it a poor candidate for short-term trading, as it can experience sharp swings on market sentiment and quarterly earnings volatility. Long-term investors can benefit from the compounding effect of its high ROE (15.1%) and the secular growth of its massive wealth management platform, which holds over $9.3 trillion in client assets. A minimum holding period of 18-24 months is suggested to ride through typical market cycles and capture the firm's fundamental value.